IN2012DN05177A - - Google Patents

Download PDF

Info

Publication number
IN2012DN05177A
IN2012DN05177A IN5177DEN2012A IN2012DN05177A IN 2012DN05177 A IN2012DN05177 A IN 2012DN05177A IN 5177DEN2012 A IN5177DEN2012 A IN 5177DEN2012A IN 2012DN05177 A IN2012DN05177 A IN 2012DN05177A
Authority
IN
India
Prior art keywords
materials
applications include
fiducial marking
implantable
iatrogenic site
Prior art date
Application number
Other languages
English (en)
Inventor
Campbell Patrick
S Sawhney Amarpreet
Original Assignee
Incept Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incept Llc filed Critical Incept Llc
Publication of IN2012DN05177A publication Critical patent/IN2012DN05177A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN5177DEN2012 2009-12-15 2010-12-15 IN2012DN05177A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28645009P 2009-12-15 2009-12-15
PCT/US2010/060474 WO2011084465A2 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers

Publications (1)

Publication Number Publication Date
IN2012DN05177A true IN2012DN05177A (de) 2015-10-23

Family

ID=44143217

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5177DEN2012 IN2012DN05177A (de) 2009-12-15 2010-12-15

Country Status (8)

Country Link
US (12) US8383161B2 (de)
EP (3) EP2512540B1 (de)
JP (1) JP5820815B2 (de)
CN (1) CN102844054B (de)
AU (1) AU2010340067B2 (de)
CA (3) CA2782899C (de)
IN (1) IN2012DN05177A (de)
WO (1) WO2011084465A2 (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675298B2 (en) * 2006-07-27 2020-06-09 Boston Scientific Scimed Inc. Particles
CN102844054B (zh) 2009-12-15 2016-04-20 因赛普特有限责任公司 植入物和能生物降解的基准标记物
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
EP2787973B1 (de) 2011-12-05 2019-10-09 Incept, LLC Medizinische organogelprozesse und -zusammensetzungen
ES2705823T3 (es) * 2012-01-24 2019-03-26 Lifecell Corp Matrices de tejidos alargadas
CN104303184B (zh) * 2012-03-21 2018-05-15 皇家飞利浦有限公司 整合医疗成像和活检数据的临床工作站以及使用其的方法
US9220807B2 (en) * 2012-11-04 2015-12-29 Miba Medical Inc. Non-toxic cross-linker for hyaluronic acid
US9226797B2 (en) * 2012-11-04 2016-01-05 Miba Medical Inc. Computer aided implantation of body implants
EP2968884B1 (de) * 2013-03-15 2018-10-03 Boston Scientific Corporation Vorrichtung zur abgabe von medikamenten
CN117982687A (zh) * 2013-03-15 2024-05-07 生物兼容英国有限公司 可成像栓塞微球
DK3003397T3 (da) * 2013-05-24 2020-11-16 Nanovi Radiotherapy A P S Gelformuleringer til styring af radioterapi
MA38709A1 (fr) 2013-06-20 2018-05-31 Nanobiotix Compositions et procédés pour une utilisation en diagnostic médical
KR102217217B1 (ko) * 2013-06-20 2021-02-18 나노비오?笭? 종양학에서의 사용을 위한 조성물 및 방법
US10842969B2 (en) 2013-10-25 2020-11-24 Mercator Medsystems, Inc. Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
US12144519B2 (en) * 2014-04-03 2024-11-19 Corbin Clinical Resources, Llc Transperineal prostate biopsy and treatment methods
US10743909B2 (en) 2014-04-03 2020-08-18 Corbin Clinical Resources, Llc Transperineal prostate biopsy device, systems, and methods of use
US10022475B2 (en) * 2014-05-01 2018-07-17 Bao Tran Body augmentation device
US9561095B1 (en) * 2015-10-12 2017-02-07 Phi Nguyen Body augmentation device
US9636210B2 (en) 2014-05-19 2017-05-02 Mentor Worldwide Llc Injection zone markers for biomedical implants
US9678022B2 (en) * 2014-09-05 2017-06-13 The Boeing Company Nonaqueous radiopaque fluid and associated imaging system and method
KR101555358B1 (ko) * 2014-10-21 2015-09-24 사회복지법인 삼성생명공익재단 생분해성 다중블록 공중합체를 이용한 표적 표지자
US10550187B2 (en) 2014-10-24 2020-02-04 Incept, Llc Extra luminal scaffold
CN120501693A (zh) 2014-12-10 2025-08-19 因赛普特有限责任公司 水凝胶药物递送植入物
NZ733130A (en) 2014-12-15 2018-09-28 Univ Johns Hopkins Sunitinib formulations and methods for use thereof in treatment of ocular disorders
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
US9855317B2 (en) 2015-04-27 2018-01-02 Reflex Medical, Inc. Systems and methods for sympathetic cardiopulmonary neuromodulation
US11369591B2 (en) 2015-05-12 2022-06-28 Incept, Llc Drug delivery from hydrogels
WO2016189125A1 (en) 2015-05-28 2016-12-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine
US20170103184A1 (en) * 2015-10-12 2017-04-13 Phi Nguyen Injectable filler
BR112018009644A2 (pt) 2015-11-12 2018-11-06 Graybug Vision Inc micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície
WO2017083753A1 (en) 2015-11-12 2017-05-18 Herr John C Compositions and methods for vas-occlusive contraception and reversal thereof
BR112018010671A8 (pt) 2015-11-25 2019-02-26 Incept Llc dispositivos e métodos de distribuição de fármaco com mudança de forma
WO2017139487A1 (en) 2016-02-09 2017-08-17 Northwind Medical, Inc. Methods, agents, and devices for local neuromodulation of autonomic nerves
CA3031761A1 (en) 2016-06-29 2018-01-04 Tulavi Therapeutics, Inc. Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
WO2018009839A1 (en) * 2016-07-07 2018-01-11 University Of Virginia Patent Foundation Thiol-michael addition hydrogel-based brachytherapy system and methods comprising the same
US20220249366A1 (en) * 2016-07-07 2022-08-11 University Of Virginia Patent Foundation Thiol-michael addition hydrogel-based brachytherapy system and methods comprising the same
CN106334213B (zh) * 2016-08-31 2019-07-26 安疗生命科学（武汉）有限公司 一种血管栓塞材料、其制备方法及在药物制备中的用途
AU2017331444B2 (en) 2016-09-23 2023-08-17 Incept, Llc Intracameral drug delivery depots
EP4082473A3 (de) * 2016-11-23 2023-01-25 Hologic, Inc. Biopsiestellenmarker
CA3053451A1 (en) 2017-01-05 2018-07-12 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
US20180289467A1 (en) * 2017-04-05 2018-10-11 Ernesto Andrade Dispensing device, kit, and method for tissue augmentation
US11160870B2 (en) 2017-05-10 2021-11-02 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
CN107307922A (zh) * 2017-07-06 2017-11-03 刘志光 一种人体植入填充颗粒的制作方法
WO2019010007A1 (en) * 2017-07-07 2019-01-10 Hindsite, Llc SYSTEM AND METHOD FOR MARKING AND FOLLOWING LOCATION OF BIOPSY SITES USING RFID TECHNOLOGY
KR102673196B1 (ko) 2017-09-05 2024-06-10 삼성전자주식회사 유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
CN111432807A (zh) 2017-10-06 2020-07-17 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
US12364792B2 (en) 2018-01-08 2025-07-22 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
EP3765098B1 (de) 2018-03-07 2024-07-24 Margin-Clear Pty Ltd Vorrichtung für topische brachytherapie
JP7560128B2 (ja) 2018-05-12 2024-10-02 ファウンドリー セラピューティクス， インコーポレイテッド 治療剤の制御放出のための埋込み可能なポリマーデポー
WO2019222064A1 (en) 2018-05-15 2019-11-21 Incept, Llc Embolic compositions and methods
AU2019299519B2 (en) 2018-07-02 2025-03-06 Incept Llc Methods and devices for in situ formed nerve cap
US20210315587A1 (en) 2018-07-02 2021-10-14 Tulavi Therapeutics, Inc. Methods and devices for in situ formed nerve cap with rapid release
WO2020047013A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics, Inc. Polymer implants
EP4461264A3 (de) 2018-09-13 2025-01-01 Allergan, Inc. Gewebeexpansionsvorrichtung
USD896383S1 (en) 2018-09-13 2020-09-15 Allergan, Inc. Tissue expansion device
EP3880273A4 (de) 2018-11-13 2022-08-24 Contraline, Inc. Systeme und verfahren zur abgabe von biomaterialien
JP2022530895A (ja) * 2019-05-03 2022-07-04 パレット ライフ サイエンシーズ，インク． 改善された組織スペーサー
WO2020249692A1 (en) * 2019-06-12 2020-12-17 Nouryon Chemicals International B.V. Method for isolating carboxylic acid from an aqueous side stream
HUE063677T2 (hu) 2019-06-12 2024-01-28 Nouryon Chemicals Int Bv Eljárás diacil-peroxidok elõállítására
WO2020249688A1 (en) 2019-06-12 2020-12-17 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
ES2963382T3 (es) 2019-06-12 2024-03-26 Nouryon Chemicals Int Bv Proceso para la producción de peróxidos de diacilo
WO2020249689A1 (en) 2019-06-12 2020-12-17 Nouryon Chemicals International B.V. Process for the production of peroxyesters
AU2020340275B2 (en) 2019-08-28 2023-06-22 Boston Scientific Scimed, Inc. Reactive multi-arm polymers having branched end groups
CN114364713A (zh) 2019-08-28 2022-04-15 波士顿科学国际有限公司 多官能氮氧化物介导的聚合引发剂和由其形成的产物
US11878092B2 (en) 2019-08-28 2024-01-23 Boston Scientific Scimed, Inc. Medical compositions based on crosslinkable hydrophilic polymers
US11326022B2 (en) 2019-08-28 2022-05-10 Boston Scientific Scimed, Inc. Multi-armed polymers comprising free-radical-polymerizable monomers and compositions, systems and methods pertaining to the same
WO2021041230A1 (en) 2019-08-28 2021-03-04 Boston Scientific Scimed, Inc. Radiopaque multi-armed polymers and compositions, systems and methods pertaining to the same
EP3958907A1 (de) 2019-08-28 2022-03-02 Boston Scientific Scimed Inc. Mehrarmige polyoxazoline und zusammensetzungen, systeme und verfahren dafür
WO2021145325A1 (ja) * 2020-01-14 2021-07-22 持田製薬株式会社 アルギン酸塩を使用した対象の処置のための組合せ及び方法
EP4100072A1 (de) 2020-02-04 2022-12-14 Boston Scientific Scimed Inc. Injizierbare in vivo vernetzende materialien zur verwendung als weichgewebe-füllstoffe
CN111905155B (zh) * 2020-07-23 2021-10-15 北京诺康达医药科技股份有限公司 一种封闭水凝胶及其制备方法和应用
US12343454B2 (en) 2020-11-12 2025-07-01 Pramand LLC Hydrogels formed in situ and composition design for intrauterine use
EP4422596A1 (de) 2021-10-25 2024-09-04 Boston Scientific Scimed Inc. Iodin-markierte hydrogele und vorläufer davon mit verbesserter radiopazität
JP2025502233A (ja) * 2022-01-13 2025-01-24 ナショナル キャンサー センター 生体親和性目的病変標識用組成物およびその製造方法
AU2023216103A1 (en) 2022-02-02 2024-06-27 Boston Scientific Scimed Inc. Iodinated compounds and hydrogels formed from same
CN114344554A (zh) * 2022-02-11 2022-04-15 上海益思妙医疗器械有限公司 一种peg化合物作为制备栓塞剂的应用
US11701451B1 (en) 2022-03-11 2023-07-18 Carbon Medical Technologies, Inc. Soft tissue filler and methods
US12251466B2 (en) 2022-04-20 2025-03-18 Pramand LLC Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels
US12440599B2 (en) 2022-05-06 2025-10-14 Pramand LLC Water activated hydrogel-based medical patches, and methods of making and using such patches
US20250360172A1 (en) * 2022-05-25 2025-11-27 Cedars-Sinai Medical Center Microgel-encapsulated ipsc-derived notochordal cells for treatment of intervertebral disc degeneration and discogenic pain
KR20250050962A (ko) 2022-08-17 2025-04-15 보스톤 싸이엔티픽 싸이메드 인코포레이티드 개선된 특성을 갖는 아이오딘 표지된 하이드로겔 및 이의 전구체
US20240174597A1 (en) 2022-11-21 2024-05-30 Boston Scientific Scimed, Inc. Iodine labeled hydrogels and crosslinking agents for forming the same
EP4673491A1 (de) 2023-03-02 2026-01-07 Boston Scientific Scimed Inc. Polyaminojodierte verbindungen und daraus hergestellte röntgendichte hydrogele
EP4673180A1 (de) 2023-03-02 2026-01-07 Boston Scientific Scimed, Inc. Hydrogele zur freisetzung eines therapeutikums und vorläufer davon
DE102023108039A1 (de) 2023-03-29 2024-10-02 Dwi - Leibniz-Institut Für Interaktive Materialien E.V. Ein System zur Herstellung eines degradierbaren Hydrogels
CN121127280A (zh) * 2023-04-28 2025-12-12 波士顿科学医学有限公司 不透射线的交联水凝胶颗粒在含有生物相容性亲水性聚合物的载体流体中的悬浮液
WO2025096930A1 (en) 2023-11-01 2025-05-08 Boston Scientific Scimed, Inc. Amino-acid- and amino-alcohol-based polyamine compounds and medical hydrogels formed therefrom
US20250228774A1 (en) * 2024-01-11 2025-07-17 Boston Scientific Scimed, Inc. Systems and methods for accelerated hydrolysis of polysaccharide-based hydrogels

Family Cites Families (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
US3865108A (en) 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3872856A (en) 1971-06-09 1975-03-25 Ralph S Clayton Apparatus for treating the walls and floor of the pelvic cavity with radiation
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
DE2437629C3 (de) 1974-08-05 1978-09-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von unlöslichen in Wasser nur wenig quellbaren Polymerisaten von N-Vinyllactamen
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4193813A (en) * 1976-09-07 1980-03-18 Medi-Coll, Inc. Method for making collagen sponge
US4207893A (en) 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
IL74715A0 (en) * 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US4697575A (en) 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4714074A (en) 1985-06-28 1987-12-22 Centre National De La Recherche Scientifique Method for protecting human or animal organs against radiation
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4741872A (en) 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
IL82834A (en) 1987-06-09 1990-11-05 Yissum Res Dev Co Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5304595A (en) * 1988-11-21 1994-04-19 Collagen Corporation Collagen-polymer conjugates
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
IL90193A (en) 1989-05-04 1993-02-21 Biomedical Polymers Int Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) * 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
DE69121587T3 (de) * 1990-12-06 2000-05-31 W.L. Gore & Associates, Newark Implantierbare bioresorbierbare artikel
FR2672713A1 (fr) * 1991-02-13 1992-08-14 Inst Nat Polytech Grenoble Composant d'alimentation du type carte de credit.
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5514379A (en) 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US6592859B1 (en) * 1992-08-20 2003-07-15 Ethicon, Inc. Controlled expansion sphincter augmentation media
WO1994005265A1 (en) * 1992-09-10 1994-03-17 Children's Medical Center Corporation Biodegradable polymer matrices for sustained delivery of local anesthetic agents
US5849035A (en) * 1993-04-28 1998-12-15 Focal, Inc. Methods for intraluminal photothermoforming
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
US5499994A (en) 1993-07-30 1996-03-19 American Medical Systems, Inc. Dilation device for the urethra
CA2188464C (en) 1994-04-27 2006-08-08 Michael Roreger Collagen preparation for the controlled release of active substances
DE4414755C2 (de) 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US6121341A (en) * 1995-03-23 2000-09-19 Board Of Regents, The University Of Texas System Redox and photoinitiator systems for priming and improved adherence of gels to substrates
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
WO1997002019A1 (en) 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
EP0842209B1 (de) * 1995-07-28 2006-10-11 Genzyme Corporation Biologische abbaubare multiblokhydrogene und ihre verwendung wie trägerstoffe fur kontrollierte freisetzung pharmakologisch activen werstoffe und gewebekontaktmaterialen
US5759583A (en) * 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
US5733316A (en) 1995-10-27 1998-03-31 Dornier Medical Systems, Inc. Organ separation for thermal therapy
CA2164262A1 (en) * 1995-12-01 1997-06-02 Charles J. Doillon Biostable porous material comprising composite biopolymers
ATE330644T1 (de) 1995-12-18 2006-07-15 Angiotech Biomaterials Corp Vernetzten polymerisatmassen und verfahren für ihre verwendung
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US6060534A (en) * 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US7049346B1 (en) * 1996-08-20 2006-05-23 Menlo Care Div Of Ethicon, Inc. Swollen hydrogel for sphincter augmentation
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US7009034B2 (en) 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
WO1998012274A1 (en) 1996-09-23 1998-03-26 Chandrashekar Pathak Methods and devices for preparing protein concentrates
ZA978537B (en) * 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US6214966B1 (en) 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
US5932539A (en) * 1996-10-15 1999-08-03 The Board Of Trustees Of The University Of Illinois Biodegradable polymer matrix for tissue repair
JP3092531B2 (ja) 1996-11-05 2000-09-25 日本油脂株式会社 コハク酸イミジル基置換ポリオキシアルキレン誘導体の製造方法
JP3092530B2 (ja) 1996-11-05 2000-09-25 日本油脂株式会社 コハク酸イミジル基置換ポリオキシアルキレン誘導体の製造方法
US6371975B2 (en) 1998-11-06 2002-04-16 Neomend, Inc. Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
IL121861A (en) 1997-09-29 2003-07-31 Moshe Ein Gal Prostate radiotherapy apparatus
US8288745B2 (en) 1997-10-10 2012-10-16 Senorx, Inc. Method of utilizing an implant for targeting external beam radiation
AU1070899A (en) * 1997-10-10 1999-05-03 Corbitt, John D. Jr. Breast implant
US6149931A (en) 1997-10-27 2000-11-21 The Regents Of The University Of California Methods and pharmaceutical compositions for the closure of retinal breaks
JP4465105B2 (ja) * 1997-11-07 2010-05-19 ルトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー 放射線不透過性ポリマー生体適合材料
US6375634B1 (en) 1997-11-19 2002-04-23 Oncology Innovations, Inc. Apparatus and method to encapsulate, kill and remove malignancies, including selectively increasing absorption of x-rays and increasing free-radical damage to residual tumors targeted by ionizing and non-ionizing radiation therapy
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US6428978B1 (en) * 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6066856A (en) 1998-05-18 2000-05-23 Children's Medical Center Corporation Radiation protective device
US6280742B1 (en) * 1998-06-17 2001-08-28 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
US6206930B1 (en) 1998-08-10 2001-03-27 Charlotte-Mecklenburg Hospital Authority Absorbable tissue expander
US6703047B2 (en) 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
US6179862B1 (en) * 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
EP1104324B8 (de) 1998-08-14 2011-06-22 Incept Llc Apparat für die in-situ-bildung von hydrogelen
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
ATE264674T1 (de) 1998-10-22 2004-05-15 Bioniche Life Sciences Inc Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
US6899889B1 (en) 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US8802146B2 (en) * 1998-11-06 2014-08-12 Neomend, Inc. Systems, methods, and compositions for prevention of tissue adhesion
WO2000028919A1 (en) 1998-11-12 2000-05-25 Canadian Prostate Centre, Inc. Apparatus and method of separating organs to enable aggressive thermal therapy
US6110484A (en) * 1998-11-24 2000-08-29 Cohesion Technologies, Inc. Collagen-polymer matrices with differential biodegradability
JP2002531217A (ja) 1998-12-04 2002-09-24 チャンドラシェカー ピー． パサック， 生体適合性架橋ポリマー
US20080114092A1 (en) 1998-12-04 2008-05-15 Incept Llc Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
TW392930U (en) * 1998-12-28 2000-06-01 Hon Hai Prec Ind Co Ltd Electric connector
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6862470B2 (en) * 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
BR0007974A (pt) 1999-02-03 2001-10-30 Powderject Res Ltd Usos de um agente farmacologicamente ativo, deum constructo de gene e de um antìgeno, métodospara produzir uma composição farmacêutica em póe para administrar uma droga a um indivìduo emnecessidade dela, composição farmacêutica, formade dosagem unitária, e, artigo de manufatura parasuprimento transdérmico ou transmucoso de umagente farmacologicamente ativo a um indivìduo
US6177514B1 (en) * 1999-04-09 2001-01-23 Sulzer Carbomedics Inc. Blocked functional reagants for cross-linking biological tissues
CA2368617C (en) * 1999-04-12 2010-03-16 Cornell Research Foundation, Inc. Hydrogel-forming system with hydrophobic and hydrophilic components
US6268405B1 (en) * 1999-05-04 2001-07-31 Porex Surgical, Inc. Hydrogels and methods of making and using same
US6426145B1 (en) 1999-05-20 2002-07-30 Scimed Life Systems, Inc. Radiopaque compositions for visualization of medical devices
US6428785B1 (en) * 1999-10-28 2002-08-06 Immunolytics Inc. Method and composition for treating prostate cancer
EP1267762A4 (de) * 1999-11-15 2005-05-25 Texas A & M Univ Sys In-situ geformter wundverband
US6479079B1 (en) * 1999-12-13 2002-11-12 Sulzer Carbomedics Inc. Anticalcification treatments for fixed biomaterials
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
US9314339B2 (en) * 2000-03-27 2016-04-19 Formae, Inc. Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement
EP1142535B1 (de) * 2000-04-07 2012-10-03 Collagen Matrix, Inc. Vorrichtung zur intravaskulären Embolisierung
US7771482B1 (en) 2000-05-09 2010-08-10 Ben-Zion Karmon Method for tissue expansion and regeneration using bioresorbable inflatable devices
US6599448B1 (en) * 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions
US6383344B1 (en) 2000-07-19 2002-05-07 Genzyme Corporation Molecular weight reduction of polymer using irradiation treatment
US6545097B2 (en) * 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US6596471B2 (en) * 2000-12-21 2003-07-22 Carbomedics Inc. Method of cross-linking tissue with a bis-maleimide compound
MXPA03007665A (es) 2001-02-26 2004-03-16 Univ Duke Polimeros dendriticos novedosos y sus usos biomedicos.
JP4123856B2 (ja) 2001-07-31 2008-07-23 日油株式会社 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法
JPWO2003031388A1 (ja) 2001-10-03 2005-01-20 大日本除蟲菊株式会社 プロパルギルベンジルアルコールエステル誘導体、その製造法、およびこれを含有する殺虫・防虫剤
US20070264227A1 (en) * 2001-11-07 2007-11-15 Eidgenossische Technische Hochschule Zurich Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration
US20040131582A1 (en) 2002-02-26 2004-07-08 Grinstaff Mark W. Novel dendritic polymers and their biomedical uses
US7341716B2 (en) * 2002-04-12 2008-03-11 Boston Scientific Scimed, Inc. Occlusive composition
US7744913B2 (en) 2002-06-24 2010-06-29 Incept, Llc Fillers and methods for displacing tissues to improve radiological outcomes
US7351430B2 (en) 2002-11-06 2008-04-01 Uluru Inc. Shape-retentive hydrogel particle aggregates and their uses
US7129210B2 (en) 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US7790141B2 (en) * 2003-08-11 2010-09-07 Pathak Holdings, Llc Radio-opaque compounds, compositions containing same and methods of their synthesis and use
US8685367B2 (en) 2003-09-25 2014-04-01 Rutgers, The State University of of New Jersey Inherently radiopaque polymeric products for embolotherapy
ES2760995T3 (es) 2004-06-23 2020-05-18 Bioprotect Ltd Dispositivo para desplazamiento o separación de tejidos
FR2872262B1 (fr) 2004-06-29 2010-11-26 Air Liquide Procede et installation de fourniture de secours d'un gaz sous pression
WO2006020616A1 (en) 2004-08-13 2006-02-23 Reva Medical, Inc. Inherently radiopaque bioresorbable polymers for multiple uses
WO2006031358A2 (en) 2004-08-13 2006-03-23 Hyperbranch Medical Technology, Inc. Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
WO2006031388A2 (en) 2004-08-20 2006-03-23 Hyperbranch Medical Technology, Inc. Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
WO2006026325A2 (en) 2004-08-26 2006-03-09 Pathak Chandrashekhar P Implantable tissue compositions and method
WO2006078770A2 (en) 2005-01-21 2006-07-27 Civco Medical Instruments Co., Inc. Creating temporary space between body tissues
US7963287B2 (en) * 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair
WO2007005249A2 (en) 2005-06-29 2007-01-11 Hyperbranch Medical Technology, Inc. Nanoparticles and dendritic-polymer-based hydrogels comprising them
DE102005051366A1 (de) * 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
AU2007204872B2 (en) 2006-01-11 2013-04-04 Hyperbranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
US8795709B2 (en) * 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
AU2007243483B2 (en) 2006-04-24 2012-07-26 Incept, Llc Protein crosslinkers, crosslinking methods and applications thereof
US7872068B2 (en) 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
CA2677532A1 (en) 2007-02-06 2008-08-14 Incept, Llc Polymerization with precipitation of proteins for elution in physiological solution
US20100104625A1 (en) 2007-02-16 2010-04-29 Cornell University Biodegradable compositions and materials
US20080220047A1 (en) 2007-03-05 2008-09-11 Sawhney Amarpreet S Low-swelling biocompatible hydrogels
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
EP2217251A4 (de) 2007-11-02 2010-11-10 Genzyme Corp Verfahren zur verstärkung der reparatur von weichteilen
CA2711455C (en) * 2008-02-13 2016-06-07 Hyperbranch Medical Technology, Inc. Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
CN101724144A (zh) 2008-11-03 2010-06-09 北京键凯科技有限公司 新型的多臂聚乙二醇及其制备方法和应用
US8916143B2 (en) 2008-11-03 2014-12-23 Cornell University Polymer compositions of dihydroxyacetone and uses thereof
CN102844054B (zh) 2009-12-15 2016-04-20 因赛普特有限责任公司 植入物和能生物降解的基准标记物
US8734930B2 (en) 2010-05-27 2014-05-27 Covidien Lp Hydrogel implants with varying degrees of crosslinking
CN105073143A (zh) 2013-02-08 2015-11-18 恩多沙普公司 用于医疗装置的不透射线的聚合物
US9789073B2 (en) 2013-03-14 2017-10-17 Pathak Holdings, Llc Compositions, methods and devices for local drug delivery
CN107759783A (zh) 2013-12-02 2018-03-06 北京键凯科技股份有限公司 炔基多臂聚乙二醇衍生物
CN106146325B (zh) 2015-04-24 2019-01-29 北京键凯科技股份有限公司 一种y型多缩乙二醇衍生物及其制备方法
US20200277449A1 (en) * 2017-09-15 2020-09-03 Université De Strasbourg Injectable hybrid alginate hydrogels and uses thereof

Also Published As

Publication number Publication date
JP2013514152A (ja) 2013-04-25
EP2512540A2 (de) 2012-10-24
CA3042067A1 (en) 2011-07-14
US20190201558A1 (en) 2019-07-04
US20170266324A1 (en) 2017-09-21
US9308283B2 (en) 2016-04-12
US20200206365A1 (en) 2020-07-02
US20110142936A1 (en) 2011-06-16
CA3042067C (en) 2022-10-18
WO2011084465A3 (en) 2011-11-17
CN102844054B (zh) 2016-04-20
CN102844054A (zh) 2012-12-26
US20140363382A1 (en) 2014-12-11
EP3960215A1 (de) 2022-03-02
CA2782899A1 (en) 2011-07-14
US10272164B2 (en) 2019-04-30
US8383161B2 (en) 2013-02-26
CA3149284A1 (en) 2011-07-14
AU2010340067B2 (en) 2015-03-19
US20200206366A1 (en) 2020-07-02
EP2512540B1 (de) 2019-08-07
US8852646B2 (en) 2014-10-07
US11154624B2 (en) 2021-10-26
US20220125954A1 (en) 2022-04-28
US20160193368A1 (en) 2016-07-07
EP3960215B1 (de) 2024-10-16
AU2010340067A1 (en) 2012-07-12
WO2011084465A2 (en) 2011-07-14
EP3583960A1 (de) 2019-12-25
CA2782899C (en) 2019-06-11
US20200206367A1 (en) 2020-07-02
US20250161497A1 (en) 2025-05-22
US11160883B2 (en) 2021-11-02
US10786581B2 (en) 2020-09-29
EP2512540A4 (de) 2013-08-14
US9669117B2 (en) 2017-06-06
US20210069353A1 (en) 2021-03-11
JP5820815B2 (ja) 2015-11-24
US20140056816A1 (en) 2014-02-27
US11083802B2 (en) 2021-08-10
US11786612B2 (en) 2023-10-17

Similar Documents

Publication Publication Date Title
IN2012DN05177A (de)
IL216036A0 (en) Highly reliable ingestible event markers and methods for using the same
BRPI0918450A2 (pt) parafuso radiolucente com marcador radiopaco
EP2877232A4 (de) Einsatzwerkzeug zur selektiven bestromung einer implantateinheit
DK2337596T3 (da) Medicinsk injektor med skraldestempel
BRPI1105769A2 (pt) insersores de dispositivo médico e processos de inserção e uso de dispositivos médicos.
ZA201207815B (en) Subcutaneous anti-her 2 antibody formulation
HUE041931T2 (hu) Jelölõeszköz
HUE044194T2 (hu) Besugárzó berendezés
IL207541A0 (en) Adhesive composition for use in an immunosensor
GB0800615D0 (en) Implantable electronic device
EP2312997A4 (de) Vorrichtungen und verfahren zur perkutanen energiefreisetzung
HRP20160726T1 (hr) Soli piperazina i postupak za njihovu pripravu
SI2421990T1 (sl) Sestavki za uporabo pri varnostnem označevanju
IL208644A0 (en) Tampon having an auxiliary patch
IL212571A0 (en) Aryl piperazine and their use as alpha2c antagonists
EP2384350A4 (de) Verfahren zur herstellung von organozinksalzen und zusammensetzungen damit
GB2477687B (en) X-ray marker
BRPI1009090A2 (pt) composto, pró-droga, medicamento, métodos, e, uso do composto
FI20095020L (fi) Menetelmä aukirullaimen yhteydessä
GB2463460B (en) Posting device
GB0801291D0 (en) Ruler
FIU20090139U0 (fi) Syöttölaite ja syöttömenetelmä
FI20090331A0 (fi) Menetelmä ja laitteisto kirjekuorien syöttämiseksi
UA29770U (ru) Применение мигрепина как вещества с противоболевыми свойствами